Speech-Language Pathologists in Chatom, AL Accepting Medicare
3 Speech-Language Pathologists found. Showing 1 - 3
 Megan Smith Gartman, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14600 Saint Stephens Ave, Chatom, AL 36518 Phone: 251-847-4294 |
Mrs. Ashton Dickey, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17527 Jordan Street, Chatom, AL 36518 Phone: 251-847-3955 |
Savanna Williams, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13154 W Central Ave, Chatom, AL 36518 Phone: 251-751-1687 |
News Archive
FDA approves first nasal glucagon therapy for treatment of severe hypoglycemia
The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection.
Autism-related proteins control nerve excitability
Two proteins that are implicated in autism have been found to control the strength and balance of nerve-cell connections, researchers at UT Southwestern Medical Center have found.
Children of parents affected with C9orf72 mutations more likely to have FTD and ALS at younger age
The most common genetic cause of the brain diseases frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) is a mutation in the C9orf72 gene.
New small-molecule inhibitor shows promising results in drug-resistant melanoma, breast cancer
LEE011, a small-molecule inhibitor of cyclin-dependent kinases (CDK) 4/6 being developed by Novartis Oncology, showed promising results in drug-resistant melanoma and drug-resistant breast cancer when tested in combination with other targeted therapies, and based on these preclinical results, several phase I clinical trials were launched recently, according to results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held October 19-23.
› Verified 2 days ago